131
Participants
Start Date
April 25, 2017
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2030
Complete responders and Non-complete responders
Patients that are complete responders will not have surgery. Patients that are non-complete responders will have surgery.
Chemoradiation + EBRT Boost
45 Gy in 25 with concomitant 5-FU or Xeloda chemotherapy) and an external beam boost of 9 Gy in 5
Chemoradiation + HDRBT Boost
45 Gy in 25 with concomitant 5-FU or Xeloda chemotherapy) and followed by a brachytherapy boost of 30 Gy in 3 fractions
TERMINATED
Hôpital Pierre Boucher, Longueuil
NOT_YET_RECRUITING
Le Centre Hospitalier de l'Université de Montreal, Montreal
RECRUITING
Jewish General Hospital, Montreal
RECRUITING
Centre hospitalier universitaire de Québec, Québec
Sir Mortimer B. Davis - Jewish General Hospital
OTHER